Capturing circulating tumor cells of hepatocellular carcinoma

Cancer Letters

Volumn 326, Issue 1, 2012, Pages 17-22

  Wu, Li Jun ^a   Pan, Yi Da ^a   Pei, Xiao Yu ^a   Chen, Hong ^b   Nguyen, Samantha ^c   Kashyap, Akshay ^c   Liu, Jie ^a   Wu, Jian ^a,c,d  

^a FUDAN UNIVERSITY   (China)

^b MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer stem cells; Circulating tumor cells; HCC thrombus formation in the portal vein; Hepatocellular carcinoma; Tumor self seeding

Indexed keywords

ALPHA FETOPROTEIN; ASIALOGLYCOPROTEIN RECEPTOR; BEVACIZUMAB; CD133 ANTIGEN; CETUXIMAB; DNA; EPITHELIAL CELL ADHESION MOLECULE; MESSENGER RNA; MICRORNA; SORAFENIB; THY 1 ANTIGEN;

CANCER STEM CELL; CANCER SURGERY; CELL DENSITY; CELL ISOLATION; CELL SIZE; CHEMOEMBOLIZATION; CIRCULATING TUMOR CELL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; IMMUNOMAGNETIC SEPARATION; LIVER CELL CARCINOMA; MICROFLUIDICS; MONITORING; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; RNA ANALYSIS; SHORT SURVEY;

EID: 84866144726     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.07.024     Document Type: Review

References (53)

1. Kaiser J. Medicine. Cancer's circulation problem. Science 2010, 327:1072-1074.
2. Ashworth A.B. A case of cancer in which cells similar to those in the tumors were seen in the blood after death. Aust. Med. J. 1869, 14:46-149.
3. Chaffer C.L., Weinberg R.A. A perspective on cancer cell metastasis. Science 2011, 331:1559-1564.
4. Guo J., Yao F., Lou Y., Xu C., Xiao B., Zhou W., Chen J., Hu Y., Liu Z. Detecting carcinoma cells in peripheral blood of patients with hepatocellular carcinoma by immunomagnetic beads and RT-PCR. J. Clin. Gastroenterol. 2007, 41:783-788.
5. Yang Z.F., Ngai P., Ho D.W., Yu W.C., Ng M.N., Lau C.K., Li M.L., Tam K.H., Lam C.T., Poon R.T., Fan S.T. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 2008, 47:919-928.
6. Lalmahomed Z.S., Kraan J., Gratama J.W., Mostert B., Sleijfer S., Verhoef C. Circulating tumor cells and sample size: the more, the better. J. Clin. Oncol. 2010, 28:e288-e289. (author reply e290).
7. Sun Y.F., Yang X.R., Zhou J., Qiu S.J., Fan J., Xu Y. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. J. Cancer Res. Clin. Oncol. 2011, 137:1151-1173.
8. Konigsberg R., Obermayr E., Bises G., Pfeiler G., Gneist M., Wrba F., de Santis M., Zeillinger R., Hudec M., Dittrich C. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients. Acta Oncol. 2011, 50:700-710.
9. Gertler R., Rosenberg R., Fuehrer K., Dahm M., Nekarda H., Siewert J.R. Detection of circulating tumor cells in blood using an optimized density gradient centrifugation. Recent results in cancer research. Fortschritte der Krebsforschung. Prog dans les recherches sur le cancer 2003, 162:149-155.
10. Balic M., Dandachi N., Hofmann G., Samonigg H., Loibner H., Obwaller A., van der Kooi A., Tibbe A.G., Doyle G.V., Terstappen L.W., Bauernhofer T. Comparison of two methods for enumerating circulating tumor cells in carcinoma patients. Cytometry Part B: Clin. Cytometry 2005, 68:25-30.
11. Vona G., Sabile A., Louha M., Sitruk V., Romana S., Schutze K., Capron F., Franco D., Pazzagli M., Vekemans M., Lacour B., Brechot C., Paterlini-Brechot P. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells. Am. J. Pathol. 2000, 156:57-63.
12. Lin H.K., Zheng S., Williams A.J., Balic M., Groshen S., Scher H.I., Fleisher M., Stadler W., Datar R.H., Tai Y.C., Cote R.J. Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin. Cancer Res. 2010, 16:5011-5018.
13. Desitter I., Guerrouahen B.S., Benali-Furet N., Wechsler J., Janne P.A., Kuang Y., Yanagita M., Wang L., Berkowitz J.A., Distel R.J., Cayre Y.E. A new device for rapid isolation by size and characterization of rare circulating tumor cells. Anticancer Res. 2011, 31:427-441.
14. Yu D., Sun X., Qiu Y., Zhou J., Wu Y., Zhuang L., Chen J., Ding Y. Identification and clinical significance of mobilized endothelial progenitor cells in tumor vasculogenesis of hepatocellular carcinoma. Clin. Cancer Res. 2007, 13:3814-3824.
15. Chen X., Lingala S., Khoobyari S., Nolta J., Zern M.A., Wu J. Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations. J. Hepatol. 2011, 55:838-845.
16. Stott S.L., Lee R.J., Nagrath S., Yu M., Miyamoto D.T., Ulkus L., Inserra E.J., Ulman M., Springer S., Nakamura Z., Moore A.L., Tsukrov D.I., Kempner M.E., Dahl D.M., Wu C.L., Iafrate A.J., Smith M.R., Tompkins R.G., Sequist L.V., Toner M., Haber D.A., Maheswaran S. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci. Transl. Med. 2010, 2. 25ra23.
17. Eifler R.L., Lind J., Falkenhagen D., Weber V., Fischer M.B., Zeillinger R. Enrichment of circulating tumor cells from a large blood volume using leukapheresis and elutriation: proof of concept. Cytometry Part B: Clin. Cytometry 2011, 80:100-111.
18. Xu W., Cao L., Chen L., Li J., Zhang X.F., Qian H.H., Kang X.Y., Zhang Y., Liao J., Shi L.H., Yang Y.F., Wu M.C., Yin Z.F. Isolation of circulating tumor cells in patients with hepatocellular carcinoma using a novel cell separation strategy. Clin. Cancer Res. 2011, 17:3783-3793.
19. Wu J., Liu P., Zhu J.L., Maddukuri S., Zern M.A. Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents. Hepatology 1998, 27:772-778.
20. Olthoff K.M., Forner A., Hubscher S., Fung J. What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?. Liver Transplant. 2011, 17:S26-33.
21. Maestro L.M., Sastre J., Rafael S.B., Veganzones S.B., Vidaurreta M., Martin M., Olivier C., DE La Orden V.B., Garcia-Saenz J.A., Alfonso R., Arroyo M., Diaz-Rubio E. Circulating tumor cells in solid tumor in metastatic and localized stages. Anticancer Res. 2009, 29:4839-4843.
22. van de Stolpe A., Pantel K., Sleijfer S., Terstappen L.W., den Toonder J.M. Circulating tumor cell isolation and diagnostics: toward routine clinical use. Cancer Res. 2011, 71:5955-5960.
23. Papavasiliou P., Fisher T., Kuhn J., Nemunaitis J., Lamont J. Circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. Proc. (Bayl. Univ. Med. Cent.) 2010, 23:11-14.
24. Bevilacqua S., Gallo M., Franco R., Rossi A., De Luca A., Rocco G., Botti G., Gridelli C., Normanno N. A " live" biopsy in a small-cell lung cancer patient by detection of circulating tumor cells. Lung Cancer 2009, 65:123-125.
25. Nagrath S., Sequist L.V., Maheswaran S., Bell D.W., Irimia D., Ulkus L., Smith M.R., Kwak E.L., Digumarthy S., Muzikansky A., Ryan P., Balis U.J., Tompkins R.G., Haber D.A., Toner M. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007, 450:1235-1239.
26. Stott S.L., Hsu C.H., Tsukrov D.I., Yu M., Miyamoto D.T., Waltman B.A., Rothenberg S.M., Shah A.M., Smas M.E., Korir G.K., Floyd F.P., Gilman A.J., Lord J.B., Winokur D., Springer S., Irimia D., Nagrath S., Sequist L.V., Lee R.J., Isselbacher K.J., Maheswaran S., Haber D.A., Toner M. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc. Natl. Acad. Sci. USA 2010, 107:18392-18397.
27. Qian J., Yao D., Dong Z., Wu W., Qiu L., Yao N., Li S., Bian Y., Wang Z., Shi G. Characteristics of hepatic IGF-II expression and monitored levels of circulating IGF-II mRNA in metastasis of hepatocellular carcinoma. Am. J. Clin. Pathol. 2010, 134:799-806.
28. Nobuoka D., Motomura Y., Shirakawa H., Yoshikawa T., Kuronuma T., Takahashi M., Nakachi K., Ishii H., Furuse J., Gotohda N., Takahashi S., Nakagohri T., Konishi M., Kinoshita T., Komori H., Baba H., Fujiwara T., Nakatsura T. Radiofrequency ablation for hepatocellular carcinoma induces glypican-3. Int. J. Oncol. 2011, 40:63-70.
29. Xu T., Lu B., Tai Y.C., Goldkorn A. A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter. Cancer Res. 2012, 70:6420-6426.
30. Min A.L., Choi J.Y., Woo H.Y., Kim J.D., Kwon J.H., Bae S.H., Yoon S.K., Shin S.H., Chung Y.J., Jung C.K. High expression of Snail mRNA in blood from hepatocellular carcinoma patients with extra-hepatic metastasis. Clin. Exp. Metast. 2009, 26:759-767.
31. Kamiyama T., Takahashi M., Nakagawa T., Nakanishi K., Kamachi H., Suzuki T., Shimamura T., Taniguchi M., Ozaki M., Matsushita M., Furukawa H., Todo S. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma. Ann. Surg. 2006, 244:451-463.
32. Borel F., Konstantinova P., Jansen P.L. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. J. Hepatol. 2012, 56:1371-1383.
33. Iida M., Iizuka N., Sakaida I., Moribe T., Fujita N., Miura T., Tamatsukuri S., Ishitsuka H., Uchida K., Terai S., Tokuhisa Y., Sakamoto K., Tamesa T., Miyamoto T., Hamamoto Y., Oka M. Relation between serum levels of cell-free DNA and inflammation status in hepatitis C virus-related hepatocellular carcinoma. Oncol. Rep. 2008, 20:761-765.
34. Tokuhisa Y., Iizuka N., Sakaida I., Moribe T., Fujita N., Miura T., Tamatsukuri S., Ishitsuka H., Uchida K., Terai S., Sakamoto K., Tamesa T., Oka M. Circulating cell-free DNA as a predictive marker for distant metastasis of hepatitis C virus-related hepatocellular carcinoma. Br. J. Cancer 2007, 97:1399-1403.
35. Fan S.T., Yang Z.F., Ho D.W., Ng M.N., Yu W.C., Wong J. Prediction of posthepatectomy recurrence of hepatocellular carcinoma by circulating cancer stem cells: a prospective study. Ann. Surg. 2011, 254:569-576.
36. Kim M.Y., Oskarsson T., Acharyya S., Nguyen D.X., Zhang X.H., Norton L., Massague J. Tumor self-seeding by circulating cancer cells. Cell 2009, 139:1315-1326.
37. Varona M.A., Del Pino J.M., Barrera M., Arranz J., Hernandez B.M., Perez H.F., Padilla J., Fuentes J.S., Aguirre A., Mendez S., Sanz P., Gianchandani R., Perera A., Soriano A. Hepatocellular carcinoma and liver transplantation: a 12-year experience. Transplant. Proc. 2009, 41:1005-1008.
38. Fouzas I., Sotiropoulos G.C., Lang H., Nadalin S., Beckebaum S., Sgourakis G., Saner F.H., Radtke A., Papanikolaou V., Baba H.A., Paul A., Broelsch C.E., Malago M. Living donor liver transplantation for hepatocellular carcinoma in patients exceeding the UCSF criteria. Transplant. Proc. 2008, 40:3185-3188.
39. Norton L., Massague J. Is cancer a disease of self-seeding?. Nat. Med. 2006, 12:875-878.
40. Pantel K., Brakenhoff R.H., Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat. Rev. Cancer 2008, 8:329-340.
41. Li N., Guo W., Shi J., Xue J., Hu H., Xie D., Wu M., Cheng S. Expression of the chemokine receptor CXCR4 in human hepatocellular carcinoma and its role in portal vein tumor thrombus. J. Exp. Clin. Cancer Res. 2010, 29:156.
42. Chu H., Zhou H., Liu Y., Liu X., Hu Y., Zhang J. Functional expression of CXC chemokine recepter-4 mediates the secretion of matrix metalloproteinases from mouse hepatocarcinoma cell lines with different lymphatic metastasis ability. Int. J. Biochem. Cell Biol. 2007, 39:197-205.
43. Scatton O., Chiappini F., Liu X.H., Riou P., Marconi A., Debuire B., Azoulay D., Lemoine A. Generation and modulation of hepatocellular carcinoma circulating cells: a new experimental model. J. Surg. Res. 2008, 150:183-189.
44. El-Serag H.B., Marrero J.A., Rudolph L., Reddy K.R. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008, 134:1752-1763.
45. Mishra L., Banker T., Murray J., Byers S., Thenappan A., He A.R., Shetty K., Johnson L., Reddy E.P. Liver stem cells and hepatocellular carcinoma. Hepatology 2009, 49:318-329.
46. Rosen J.M., Jordan C.T. The increasing complexity of the cancer stem cell paradigm. Science 2009, 324:1670-1673.
47. Lingala S., Cui Y.Y., Chen X., Ruebner B.H., Qian X.F., Zern M.A., Wu J. Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. Exp. Mol. Pathol. 2010, 89:27-35.
48. Haraguchi N., Ishii H., Mimori K., Tanaka F., Ohkuma M., Kim H.M., Akita H., Takiuchi D., Hatano H., Nagano H., Barnard G.F., Doki Y., Mori M. CD13 is a therapeutic target in human liver cancer stem cells. J. Clin. Invest. 2010, 120:3326-3339.
49. Oliva J., French B.A., Qing X., French S.W. The identification of stem cells in human liver diseases and hepatocellular carcinoma. Exp. Mol. Pathol. 2010, 88:331-340.
50. Ma S., Chan K.W., Hu L., Lee T.K., Wo J.Y., Ng I.O., Zheng B.J., Guan X.Y. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007, 132:2542-2556.
51. Yamashita T., Ji J., Budhu A., Forgues M., Yang W., Wang H.Y., Jia H., Ye Q., Qin L.X., Wauthier E., Reid L.M., Minato H., Honda M., Kaneko S., Tang Z.Y., Wang X.W. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 2009, 136:1012-1024.
52. Yang Z.F., Ho D.W., Ng M.N., Lau C.K., Yu W.C., Ngai P., Chu P.W., Lam C.T., Poon R.T., Fan S.T. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 2008, 13:153-166.
53. Kudo M. Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma. Dig. Dis. 2011, 29:289-302.